Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic Dermatitis

NCT07437534 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

148

Enrollment

OTHER_GOV

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Crisaborole 2% Topical Application Ointment [EUCRISA
DRUG: tacrolimus 0.1%

Sponsor

Hayat Abad Medical Complex, Peshawar